In contrast to the role of GIPC2 as a putative tumor suppressor in ALL and PPGLs [28], [24], the potential oncogenic function of GIPC2 in PCa demonstrated a cell-type dependent function. The gene discussed is GIPC2; the disease is posterior cortical atrophy.